The drug brexpiprazole (Rexulti) is approved to treat agitation in Alzheimer’s, and the drug suvorexant (Belsomra) is approved to treat insomnia in people with Alzheimer’s. Research efforts on new Alzheimer’s treatments have been frustrating, with promising drug candidates often failing in clinic...